Thorsten M. Schlaeger is a German American biologist who is the head of the Human Embryonic Stem Cell Core Facility of the Stem Cell Program at Boston Children's Hospital.[1]

He studied Human Biology (Humanbiologie) at the University of Marburg and performed his Ph.D. thesis work in the laboratories of Werner Risau and Tom Sato.[2] In 1999 he was awarded the Otto Hahn Medal of the Max Planck Society for his Ph.D. thesis on endothelial cell specific gene expression.[3] Following his postdoctoral research in the laboratory of Stuart Orkin and a short foray into industry, he re-joined Boston Children's Hospital where he works with Leonard I. Zon and George Q. Daley to develop induced pluripotent stem cell based transfusion and transplantation products.[2] His laboratory focuses on human pluripotent stem cell biology, genome editing, reprogramming, laboratory automation, chemical genetics, and imaging technologies.[1]

Google Scholar shows that ten of his papers have been cited more than 100 times each.[4]

References

  1. 1 2 "The hESC Core Facility | Boston Children's Hospital". stemcell.childrenshospital.org. Retrieved 2016-08-09.
  2. 1 2 "Thorsten M. Schlaeger, PhD | Boston Children's Hospital". stemcell.childrenshospital.org. Retrieved 2016-08-09.
  3. ↑ "Thorsten Schlaeger, PhD | Research + Innovation | Boston Children's Hospital". www.childrenshospital.org. Retrieved 2016-08-09.
  4. ↑ "Google Scholar".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.